Among the medications that have been assessed in pediatric patients with EoE with different success, are corticosteroids (oral systemic and topical), cromolyn sodium, leukotriene receptor antagonists, and biologics (mainly anti-IgE and anti-IL-5 monoclonal antibodies). The gene discussed is IGHE; the disease is eosinophilic esophagitis.